病毒過濾市場規模、佔有率、成長分析（按產品、應用、最終用戶、地區）- 產業預測，2025 年至 2032 年

全球病毒過濾市場規模預計在 2023 年達到 53 億美元，到 2032 年將達到 128.1 億美元，預計在預測期內（2025-2032 年）的複合年成長率為 10.3%。

全球病毒過濾市場正在經歷顯著成長，這得益於對需要嚴格病毒安全通訊協定的生技藥品的需求不斷成長。隨著生物製藥公司專注於開發先進的治療方法，病毒過濾在確保產品純度方面發揮關鍵作用，尤其是在單株抗體和重組蛋白中。不斷增加的研發投入和政府的支持政策也在增強生物製造能力。一個值得注意的趨勢是注重技術創新，主要企業都在投資下一代薄膜技術和一次性過濾系統，以提高吞吐量並最大限度地降低污染風險。市場正在擴展到醫療設備、水處理和空氣淨化應用領域。過濾的自動化以及製造商和生物加工公司之間的策略聯盟正在進一步加速客製化解決方案和驗證通訊協定的開發。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究

病毒過濾市場規模（按產品和複合年成長率） (2025-2032)

• 市場概覽
• 套件和試劑
• 過濾系統
• 服務
• 其他產品

病毒過濾市場規模（按應用分類）及複合年成長率（2025-2032）

• 市場概覽
• 生技藥品
  • 疫苗和治療
  • 血液和血液製品
  • 細胞和基因療法產品
  • 紙巾及紙巾製品
  • 幹細胞產品
• 醫療設備
• 水淨化
• 空氣淨化

病毒過濾市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 製藥和生物技術公司
• 合約研究組織
• 學術研究所
• 醫療設備公司

病毒過濾市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益同比對比（2022-2024 年）

主要企業簡介

• Merck KGaA
• Danaher
• Sartorius AG
• Thermo Fisher Scientific Inc.
• GE HealthCare
• Charles River Laboratories
• Asahi Kasei Medical Co., Ltd.
• Sartorius AG
• Lonza
• Sigma-Aldrich Corporation
• Clean Biologics

結論和建議

Global Virus Filtration Market size was valued at USD 5.3 billion in 2023 and is poised to grow from USD 5.85 billion in 2024 to USD 12.81 billion by 2032, growing at a CAGR of 10.3% during the forecast period (2025-2032).

The global virus filtration market is experiencing significant growth, driven by the rising demand for biologics that require stringent viral safety protocols. As biopharmaceutical companies focus on developing advanced therapies, virus filtration plays a crucial role in ensuring product purity, especially for monoclonal antibodies and recombinant proteins. Increased R&D investments and supportive government initiatives are also enhancing biomanufacturing capabilities. A notable trend is the focus on technological innovation, with key players investing in next-generation membrane technologies and single-use filter systems that improve throughput and minimize contamination risks. The market is expanding into medical devices, water treatment, and air purification applications. Automation of filtration processes and strategic collaborations between manufacturers and bioprocessing firms further accelerate the development of tailored solutions and validation protocols.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Virus Filtration market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Virus Filtration Market Segments Analysis

Global Virus Filtration Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Kits and Reagents, Filtration Systems, Services and Other Products. Based on Application, the market is segmented into Biologicals, Medical Devices, Water Purification and Air Purification. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic Research Institutes and Medical Device Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Virus Filtration Market

The global virus filtration market is experiencing significant growth driven by the increasing adoption of biologic therapies and mRNA-based vaccines. As biopharmaceutical and biomanufacturing companies embark on developing innovative treatments such as monoclonal antibodies, recombinant proteins, and gene therapies, the necessity for stringent viral safety measures throughout the manufacturing process has become paramount. This heightened focus on viral safety stems from the rapid expansion of biologic pipelines, compelling manufacturers to invest in effective virus-removal filters to adhere to stringent purity regulations. Consequently, the demand for advanced virus filtration systems is closely linked to the overall growth of biological production on a global scale.

Restraints in the Global Virus Filtration Market

The global virus filtration market faces significant constraints due to the high initial capital costs associated with emerging virus filtration technologies, such as single-use systems or nanofiber membranes. Smaller and mid-sized biopharmaceutical companies often struggle to allocate budgets for expensive capital equipment, custom consumables, and the necessary skilled personnel. Moreover, the considerable operating expenses linked to routine filter replacements and validation studies can deter these companies from making investments in new technologies. This is particularly pronounced in developing markets, where funding limitations can hinder the acquisition of advanced sterilizing filtration systems, ultimately stalling progress in the adoption of innovative filtration solutions.

Market Trends of the Global Virus Filtration Market

The Global Virus Filtration market is witnessing a significant shift towards single-use and continuous bioprocessing platforms, driven by manufacturers seeking enhanced efficiency and safety in downstream purification processes. Single-use filtration systems minimize the risk of cross-contamination, reduce changeover times, and eliminate the necessity for extensive cleaning-validated procedures, making them particularly attractive for multiproduct facilities. Furthermore, continuous bioprocessing enhances productivity by allowing for seamless viral-clearance steps, thus increasing throughput while ensuring robust viral safety measures. This trend towards modular, disposable units aligns with the industry's flexibility objectives, enabling quick deployment and reconfiguration in response to fluctuating production demands, ultimately accelerating time-to-market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies

Global Virus Filtration Market Size by Product & CAGR (2025-2032)

• Market Overview
• Kits and Reagents
• Filtration Systems
• Services
• Other Products

Global Virus Filtration Market Size by Application & CAGR (2025-2032)

• Market Overview
• Biologicals
  • Vaccines and Therapeutics
  • Blood and Blood Products
  • Cellular and Gene Therapy Products
  • Tissue and Tissue Products
  • Stem Cell Products
• Medical Devices
• Water Purification
• Air Purification

Global Virus Filtration Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic Research Institutes
• Medical Device Companies

Global Virus Filtration Market Size & CAGR (2025-2032)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE HealthCare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Medical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sigma-Aldrich Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clean Biologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations